The prevalence of Helicobacter pylori infection in patients with peptic ulcer disease complicated by haemorrhage after assumption of nonsteroidal anti-inflammatory drugs

Not Applicable

Completed

• Conditions: Helicobacter pylori infection and NSAIDs use in patients with peptic ulcer disease complicated by haemorrhage; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12607000521426
• Lead Sponsor: Dr. Antonio Balzano

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-10-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients with peptic ulcer disease complicated by haemorrhage (Hematemesis, melena, ematochezia, or with other clinical signs of blood loss - i.e., hemodynamic instability with hypotension and tachycardia) within 72 hours before admission;
Continuative or occasional use of nonsteroidal anti-inflammatory drugs within 30 days before admission;
Ulcer with a diameter of at least 5 mm;
Ability to understand and follow the protocol requirements;
Having given written informed consent form for study participation

Exclusion Criteria

Patients in treatment with antibiotics and proton-pump inhibitors within 4 weeks before the enrolment;
Patients with upper gastrointestinal neoplastic ulcer

Study & Design

• Study Type: Observational
• Study Design: Not specified